How did Unity Biotechnology Inc (UBX) fare last session?

While Unity Biotechnology Inc has overperformed by 2.37%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, UBX fell by -1.70%, with highs and lows ranging from $2.02 to $0.94, whereas the simple moving average jumped by 22.03% in the last 200 days.

On August 22, 2024, Rodman & Renshaw started tracking Unity Biotechnology Inc (NASDAQ: UBX) recommending Buy. A report published by Wedbush on November 16, 2023, Upgraded its rating to ‘Outperform’ for UBX. Mizuho November 10, 2021d the rating to Buy on November 10, 2021, and set its price target from $5 to $7. Citigroup June 28, 2021d its ‘Sell’ rating to ‘Buy’ for UBX, as published in its report on June 28, 2021. H.C. Wainwright’s report from June 07, 2021 suggests a price prediction of $12 for UBX shares, giving the stock a ‘Buy’ rating. Citigroup also rated the stock as ‘Sell’.

Analysis of Unity Biotechnology Inc (UBX)

In order to gain a clear picture of Unity Biotechnology Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -86.95% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.45, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 148.57K can be a very valuable indicator of volatility for UBX stock. On a monthly basis, the volatility of the stock is set at 12.63%, whereas on a weekly basis, it is put at 10.01%, with a loss of -3.35% over the past seven days. Furthermore, long-term investors anticipate a median target price of $6.50, showing growth from the present price of $1.73, which can serve as yet another indication of whether UBX is worth investing in or should be passed over.

How Do You Analyze Unity Biotechnology Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 8.80%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 13.14% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

UBX shares are owned by institutional investors to the tune of 13.14% at present.

Related Posts